Radiotheranostics: a roadmap for future development

The Lancet Oncology
Ken HerrmannRalph Weissleder

Abstract

Radiotheranostics, injectable radiopharmaceuticals with antitumour effects, have seen rapid development over the past decade. Although some formulations are already approved for human use, more radiopharmaceuticals will enter clinical practice in the next 5 years, potentially introducing new therapeutic choices for patients. Despite these advances, several challenges remain, including logistics, supply chain, regulatory issues, and education and training. By highlighting active developments in the field, this Review aims to alert practitioners to the value of radiotheranostics and to outline a roadmap for future development. Multidisciplinary approaches in clinical trial design and therapeutic administration will become essential to the continued progress of this evolving therapeutic approach.

Citations

Sep 8, 2020·Chembiochem : a European Journal of Chemical Biology·Alberto Dal Corso
May 14, 2020·The British Journal of Radiology·Sofia C VazPatrick Veit-Haibach
Nov 13, 2020·EJNMMI Radiopharmacy and Chemistry·Melissa E RodnickPeter J H Scott
Nov 24, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Antje DietrichMechthild Krause
Jul 11, 2020·Nuclear Medicine and Biology·Antony D GeePeter J H Scott
Sep 6, 2020·Bioconjugate Chemistry·Roberto FanelliFlorine Cavelier
Apr 9, 2021·Nuclear Medicine and Biology·Giacomo PirovanoThomas Reiner
May 12, 2021·European Journal of Nuclear Medicine and Molecular Imaging·W V VogelM W J Versleijen
Dec 10, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wolfgang A WeberH William Strauss
Jun 1, 2021·PET Clinics·Hossein ShooliMajid Assadi
Jun 24, 2021·British Journal of Clinical Pharmacology·Erik T Te BeekMarc R J Ten Broek
Jul 3, 2021·Cancers·Yuchen JinWeijun Wei
Jun 14, 2021·European Journal of Nuclear Medicine and Molecular Imaging·M J M UijenJ Nagarajah
Jul 9, 2021·Nuclear Medicine and Biology·Noami DaemsAn Aerts
Nov 29, 2020·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sangeeta Ray BanerjeeMartin G Pomper
Jul 29, 2021·Molecular Pharmaceutics·Thomas WilsonJill Bargonetti
Aug 18, 2021·Molecular Pharmaceutics·Kazuma OgawaSeigo Kinuya
Aug 26, 2021·The British Journal of Radiology·Jonathan GearJill Tipping
Oct 29, 2021·Journal of Medicinal Chemistry·Hiroyuki SuzukiYasushi Arano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.